Thu 25 Jun 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
| Product | Date | Safety information | Attachments |
|---|---|---|---|
| AVASTIN® - Bevacizumab | Cases of Necrotizing Fasciitis Reported with AVASTIN |
||
| MabThera® - Rituximab | Risk of Toxic Epidermal Necrolysis And Stevens-Johnson-Syndrome |
||
| SPRYCEL® - Dasatinib | Risk of (PAH) Pulmonary Arterial Hypertension |
||
| Valdoxan® - Agomelatine | Risk of hepatotoxicity with agomelatine |
||
| Arava® - leflunomide | Risk of hepatotoxicity Risk of serious birth defects |
||
| Wellbutrin®/Zyban® - bupropion | Increased risk of congenital cardiovascular malformations |
||
| Gilenya® - fingolimod | Cardiovascular adverse events after the first dose of Gilenya® |
||
| Zofran® - ondansetron | Risk of developing abnormal changes in the electrical activity of the heart |
||
| Avastin® - bevacizumab | Reports of severe infectious endophthalmitis following unapproved intravitreal injection use |
||
| Actos® - pioglitazone | Risk of bladder cancer |
Last update date: 21/04/2024 at 10:00 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.